Valuation : Yuhan Corporation

Market Cap 6,331B 4.6B 3.98B 3.71B 3.41B 6.4B 438B 6.43B 44.18B 17.26B 222B 17.25B 16.88B 738B P/E 2026 *
42.6x
P/E 2027 * 30.9x
Enterprise Value 6.25B 4.54M 3.93M 3.66M 3.36M 6.32M 433M 6.35M 43.62M 17.05M 219M 17.03M 16.66M 729M EV / Sales 2026 *
2.67x
EV / Sales 2027 * 2.41x
Free-Float
69.5%
Yield 2026 *
0.67%
Yield 2027 * 0.68%
1 day+2.66%
1 week+3.16%
Current month+15.51%
1 month+20.77%
3 months-0.12%
6 months-22.96%
Current year-24.47%
1 week 81,450
Extreme 81450
87,100
1 month 71,300
Extreme 71300
87,500
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap.
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.66%+3.16%-25.20%+22.62% 4.59B
-0.80%-2.75%+76.36%+34.88% 366B
+0.11%+1.67%+29.50%-14.59% 70.76B
-1.47%-2.61%+44.02%+144.43% 11.96B
+1.74%+3.38%+4.66%+0.32% 8.72B
0.00%+5.14%-10.75%+2.56% 5B
-1.79%-1.23%-28.47%+3.73% 3.16B
-1.04%-4.62%-3.08%+38.12% 2.54B
-5.18%-1.51%-16.06%-11.49% 2.08B
+0.35%+2.36%-22.75%-14.93% 1.73B
Average -0.54%+0.59%+4.82%+20.57% 47.65B
Weighted average by Cap. -0.62%-1.82%+63.50%+28.62%

Financials

2026 *2027 *
Net sales 2,340B 1.7B 1.47B 1.37B 1.26B 2.37B 162B 2.38B 16.33B 6.38B 81.95B 6.38B 6.24B 273B 2,556B 1.86B 1.6B 1.5B 1.37B 2.58B 177B 2.6B 17.83B 6.97B 89.49B 6.96B 6.81B 298B
Net income 154B 112M 96.54M 90.08M 82.7M 155M 10.64B 156M 1.07B 419M 5.38B 419M 410M 17.93B 206B 150M 129M 121M 111M 208M 14.26B 209M 1.44B 562M 7.21B 561M 549M 24.02B
Net Debt -80.13B -58.26M -50.32M -46.96M -43.11M -81.01M -5.55B -81.41M -559M -219M -2.81B -218M -214M -9.35B -162B -118M -102M -94.83M -87.06M -164M -11.2B -164M -1.13B -441M -5.67B -441M -431M -18.88B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-08-28 ₩84,900.00 +2.66% 183,873
26-08-27 ₩82,700.00 -4.61% 376,123
26-08-26 ₩86,700.00 +4.08% 314,903
26-08-25 ₩83,300.00 -1.19% 178,548
26-08-24 ₩84,300.00 +2.43% 239,672
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
84,900.00KRW
Average target price
120,111.11KRW
Spread / Average Target
+41.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock